A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ACC/AHA / American Heart Association

[Related PubMed/MEDLINE]
Total Number of Papers: 354
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ACC/AHA  (>> Co-occurring Abbreviation)
Long Form:   American Heart Association
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A Comparison of Four Cardiovascular Risk Assessment Instruments in Saudi Patients. CVD, FRS, HDL, SCORE
2020 Apparent treatment-resistant hypertension: characteristics and prevalence in a real-world environment of an integrated health system. aTRH, BP
2020 Assessment of the Efficacy of Lowering LDL Cholesterol with Rosuvastatin 10 mg in Four Korean Statin Benefit Groups as per ACC/AHA Guidelines (NewStaR4G). LDL
2020 Association between Blood Heavy Metal Levels and Predicted 10-Year Risk for A First Atherosclerosis Cardiovascular Disease in the General Korean Population. ASCVD, Cd, KNHANES, KRPM
2020 Association between blood pressure levels and cardiovascular deaths: a 20-year follow-up study in rural China. BP, CVDs, DBP, SBP
2020 Associations between ideal blood pressure based on different BMI categories and stroke incidence. BP
2020 Blood pressure control and complex health conditions in older adults: impact of recent hypertension management guidelines. BP, ESC/ESH
2020 Blood Pressure Measurement: A KDOQI Perspective. BP, CKD, KDOQI
2020 Comparison and Implication of the Contemporary Blood Pressure Guidelines on Korean Population. BP, KSH
10  2020 Compliance to dietary guidelines on fruit and vegetable intake and prevalence of hypertension among Vietnamese adults, 2015. DASH, JNC7
11  2020 Coronary Artery Calcium for Personalized Allocation of Aspirin in Primary Prevention of Cardiovascular Disease in 2019: The Multi-Ethnic Study of Atherosclerosis (MESA). ASCVD, CAC, MESA, PCE, RRR
12  2020 Effects of the 2013 American College of Cardiology/American Heart Association guidelines on racial and ethnic disparities in statin treatment among diabetics. DID
13  2020 Glycated Hemoglobin, Prediabetes, and the Links to Cardiovascular Disease: Data From UK Biobank. CVD, HR, NRI, SCORE
14  2020 Grip Strength and Walking Pace and Cardiovascular Disease Risk Prediction in 406,834 UK Biobank Participants. CVD, SCORE
15  2020 Impact of the 2017 American College of Cardiology/American Heart Association Guidelines on Prevalence of Hypertension in Ghana. ---
16  2020 Impact of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline on the prevalence of hypertension in young Saudi women. BMI
17  2020 Impact of the new criteria of the ACC/AHA on the diagnostic prevalence of hypertension. DBP
18  2020 One-year clinical results of the NANO registry: A multicenter, prospective all-comers registry study in patients receiving implantation of a polymer-free sirolimus-eluting stent. AMI, DES, ST, TLF, TLR, TV-MI
19  2020 Pooled cohort risk equation and subclinical cerebrovascular diseases. AOR, CI, CMB, PCR, WMH
20  2020 Request for an Andexxa Value Analysis. ---
21  2020 Socioeconomic differentials in hypertension based on JNC7 and ACC/AHA 2017 guidelines mediated by body mass index: Evidence from Nepal demographic and health survey. BMI, CVD, LMICs
22  2020 Spotlight from the American Society for Preventive Cardiology on Key Features of the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guidelines on the Management of Blood Cholesterol. ASCVD, CKD, LDL-C, PCSK9
23  2019 2017 ACC/AHA Blood Pressure Classification and Cardiovascular Disease in 15 Million Adults of Age 20-94 Years. BP, CVD
24  2019 ACC/AHA 2017 definition of high blood pressure: implications for women with polycystic ovary syndrome. BMI, CI, HDL, PCOS, SAH
25  2019 Agreement between 2017 ACC/AHA Hypertension Clinical Practice Guidelines and Seventh Report of the Joint National Committee Guidelines to Estimate Prevalence of Postmenopausal Hypertension in a Rural Area of Bangladesh: A Cross Sectional Study. HTN, ISH, JNC7, PABAK
26  2019 Ambulatory blood pressure monitoring in clinical practice. ABPM, BP
27  2019 Awareness of Physicians and Clinical Pharmacists About ACC/AHA Guidelines for Dyslipidemia Management: A Cross-Sectional Study. CVDs
28  2019 Blood pressure trajectory and category and risk of hypertensive disorders of pregnancy in nulliparous women. ---
29  2019 Body of Evidence in Favor of Adopting 130/80 mm Hg as New Blood Pressure Cut-Off for All the Hypertensive Disorders of Pregnancy. ACOG
30  2019 Cardiovascular Disease and Mortality in Adults Aged ≥60 Years According to Recommendations by the American College of Cardiology/American Heart Association and American College of Physicians/American Academy of Family Physicians. JHS
31  2019 Comparison of the JNC7 and 2017 American College of Cardiology/American Heart Association Guidelines for the Management of Hypertension in Koreans: Analysis of Two Independent Nationwide Population-Based Studies. BP, HRs, JNC7, KNHANES, NHIS-HEALS
32  2019 Development of a risk score to identify patients with type 2 diabetes mellitus and multivessel coronary artery disease who can defer bypass surgery. BARI 2D, CABG, CAD, IMT, MI
33  2019 Diagnostic Performance of Blood Pressure Measurement Modalities in Living Kidney Donor Candidates. ---
34  2019 Differential Clinical Profiles, Exercise Responses, and Outcomes Associated With Existing HFpEF Definitions. ESC, HFpEF, HFSA
35  2019 Discrimination between Obstructive Coronary Artery Disease and Cardiac Syndrome X in Women with Typical Angina and Positive Exercise Test; Utility of Cardiovascular Risk Calculators. ASCVD, AUROC, CAD, CAG, CSX, ETT, FRS, SCORE
36  2019 Effect of Blood Pressure on Cardiovascular Diseases at 10-Year Follow-Up. BP, CVD
37  2019 Effect of vitamin D supplementation on cardiovascular risk in type 2 diabetes. CVD, TG
38  2019 Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy. HCM, ICDs, SCD
39  2019 Gender difference in the association between brachial-ankle pulse wave velocity and cardiovascular risk scores. ATP, baPWV, CVD, FRS
40  2019 Have the Government's prescription algorithm and the 2013 American College of Cardiology/American Heart Association guidelines for managing dyslipidaemia influenced the management of dyslipidaemia? The MEJORALO-CV Project. ---
41  2019 Hypertension guidelines: Treat patients, not numbers. ---
42  2019 Impact of Single-Occasion American vs. Canadian Office Blood Pressure Measurement Recommendations on Blood Pressure Classification. AHT, BPM, CHEP, OBP
43  2019 Impact of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines on the Next Blood Pressure Guidelines in Asia. BP
44  2019 Impact of the European and American guidelines on hypertension prevalence, treatment, and cardiometabolic goals. BP, ESC/ESH
45  2019 Impacts of the New 2017 ACC/AHA Hypertension Guideline on the Prevalence of Brachial Hypertension and Its Concordance with Central Hypertension. BP
46  2019 Implications of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline in a Modern Primary Prevention Multi-Ethnic Prospective Cohort (Multi-Ethnic Study of Atherosclerosis). JNC
47  2019 Increased burden of coronary artery calcium from elevated blood pressure in low-risk young adults. BP, CAC, CIs, CVD, PRs
48  2019 Increases in statin eligibility to reduce cardiovascular risk according to the 2013 ACC/AHA cholesterol guidelines in the Africa Middle East region: a sub-analysis of the Africa Middle East Cardiovascular Epidemiological (ACE) study. ACE, CI
49  2019 Ineffective Antibiotic Prophylaxis: An Unusual Presentation of Infective Endocarditis with Insights into the Appropriateness of Prophylaxis. IE
50  2019 KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline. BP, ERA-EDTA, KDOQI
51  2019 Learning from Longitudinal Data in Electronic Health Record and Genetic Data to Improve Cardiovascular Event Prediction. CNN, CVD, EHR, LSTM
52  2019 Levels of Evidence Supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018. ESC, LOE, RCTs
53  2019 Network Analysis of Citation in Hypertension Clinical Guidelines. ESC/ESH
54  2019 New blood pressure cut off for preeclampsia definition: 130/80 mmHg. ACOG, ISSHP
55  2019 Prevalence of ambulatory blood pressure phenotypes using the 2017 American College of Cardiology/American Heart Association blood pressure guideline thresholds: data from the Coronary Artery Risk Development in Young Adults study. BP
56  2019 Prevalence of hypertension among office workers in a multi-national company in the Niger-Delta with the 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines. BP, FRS
57  2019 Prevalence of hypertension and blood pressure profile amongst urban-dwelling adults in Nigeria: a comparative analysis based on recent guideline recommendations. JNC7
58  2019 Prevalence of Hypertension, Treatment, and Blood Pressure Targets in Canada Associated With the 2017 American College of Cardiology and American Heart Association Blood Pressure Guidelines. BP
59  2019 Racial/ethnic disparities in prevalence, treatment, and control of hypertension among US adults following application of the 2017 American College of Cardiology/American Heart Association guideline. CI
60  2019 Relationship Between Brachial-Ankle Pulse Wave Velocity and Incident Hypertension According to 2017 ACC/AHA High Blood Pressure Guidelines. baPWV
61  2019 Relationship of the Blood Pressure Categories, as Defined bythe ACC/AHA2017 Blood Pressure Guidelines, and the Risk ofDevelopment of Cardiovascular Disease in Low-Risk YoungAdults: Insights From a Retrospective Cohort of YoungAdults. BP, CVD
62  2019 Stage 1 hypertension defined by the 2017 ACC/AHA guideline predicts future cardiovascular events in elderly Chinese individuals. BP, CVD, DBP, HRs, MI, SBP
63  2019 Statin Use in Primary Prevention: A Simple Trial-Based Approach Compared With Guideline-Recommended Risk Algorithms for Selection of Eligible Patients. ARR, CI, FRS, HOPE
64  2019 Statin Use in the U.S. for Secondary Prevention of Cardiovascular Disease Remains Suboptimal. ASCVD, OR
65  2019 Status of Hypertension in Tehran: Potential impact of the ACC/AHA 2017 and JNC7 Guidelines, 2012-2015. BP
66  2019 Subclinical Coronary Atherosclerosis: Implication of Coronary Computed Tomography Angiography Findings among Statin Candidates according to the 2013 ACC/AHA Cholesterol Management Guidelines. CAD, CCTA, CVD, MACEs, SR
67  2019 The Comparative Effect of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on 10-Year and Lifetime Atherosclerotic Cardiovascular Disease Risk. ASCVD, RYGB, SG
68  2019 The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry. ACS, AMI, BMI, CKD, DM, GDMT, LVEF, MACE, PCI, STEMI, TVR
69  2019 Treatment Gap in Primary Prevention Patients Presenting With Acute Coronary Syndrome. 10yASCVD, ACS
70  2019 Trends in Guideline-Driven Revascularization in Diabetic Patients with Multivessel Coronary Heart Disease. CABG, CI, PCI
71  2019 Trends in low-density lipoprotein-cholesterol blood values between 2012 and 2017 suggest sluggish adoption of the recent 2013 treatment guidelines. ATP, LDL
72  2019 Unintended consequences of the new ACC/AHA blood pressure treatment guidelines. BP, SBP
73  2019 Unique cardiovascular risk factors in women. CVD
74  2019 Updated hypertension prevalence, awareness, and control rates based on the 2017ACC/AHA high blood pressure guideline. HBP
75  2019 Urban-Rural disparities in status of hypertension in northeast China: a population-based study, 2017-2019. CI, OR
76  2018 2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk. BP, CI, CVD, DBP, SBP
77  2018 A Comparison of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline and the 2017 American Diabetes Association Diabetes and Hypertension Position Statement for U.S. Adults With Diabetes. ADA, BP, NHANES
78  2018 ACC/AHA Versus ESC Guidelines on DualAntiplatelet Therapy: JACC Guideline Comparison. CAD, DAPT, ESC
79  2018 Anaesthesia management for bronchoscopic and surgical lung volume reduction. BLVR, LVR, SLVR
80  2018 Assessing gaps in cholesterol treatment guidelines for primary prevention of cardiovascular disease based on available randomised clinical trial evidence: The Rotterdam Study. CVD, ESC
81  2018 Association of Blood Pressure Classification in Korean Young Adults According to the 2017 American College of Cardiology/American Heart Association Guidelines With Subsequent Cardiovascular Disease Events. CHD, CVD, HR
82  2018 Association of Blood Pressure Classification in Young Adults Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Cardiovascular Events Later in Life. ACC, AHA, BP, CARDIA, CHD, CVD, DBP, PAD, SBP
83  2018 Audit of Postoperative Surgical Intensive Care Unit Admissions. ASA, SICU
84  2018 Blood Pressure Control and Cardiovascular Outcomes: Real-world Implications of the 2017 ACC/AHA Hypertension Guideline. BP, MACEs
85  2018 Clinical characteristics, patterns of lipid-lowering medication use, and health care resource utilization and costs among patients with atherosclerotic cardiovascular disease. ASCVD, HCRU, LDL-C, LLM
86  2018 Combination Lipid-Lowering Therapies for the Prevention of Recurrent Cardiovascular Events. ---
87  2018 Comparison of Five Major Guidelines for Statin Use in Primary Prevention in a Contemporary General Population. ASCVD, CCS, ESC/EAS, NICE, USPSTF
88  2018 Coronary Artery Calcium: Recommendations for Risk Assessment in Cardiovascular Prevention Guidelines. ASCVD, CAC, PCE, SCCT
89  2018 Differences in primary cardiovascular disease prevention between the 2013 and 2016 cholesterol guidelines and impact of the 2017 hypertension guideline in the United States. ---
90  2018 Discordance of the Framingham cardiovascular risk score and the 2013 American College of Cardiology/American Heart Association risk score in systemic lupus erythematosus and rheumatoid arthritis. CV, RA, SLE
91  2018 Estimated Change in Prevalence of Hypertension in Nepal Following Application of the 2017 ACC/AHA Guideline. ---
92  2018 Evaluation of Statin Eligibility, Prescribing Practices, and Therapeutic Responses Using ATP III, ACC/AHA, and NLA Dyslipidemia Treatment Guidelines in a Large Urban Cohort of HIV-Infected Outpatients. ATP III, NLA
93  2018 High Brachial Ankle Pulse Wave Velocity as a Marker for Predicting Coronary Artery Stenosis in Patients with Type 2 Diabetes. AUC, baPWV, CAS, CI, CVD, MSCT, UKPDS
94  2018 Ideal Blood Pressure in Patients With Atrial Fibrillation. AF, BP
95  2018 Impact of the American College of Cardiology/American Heart Association Cholesterol Guidelines on Statin Eligibility Among Human Immunodeficiency Virus-Infected Individuals. ATP III, CVD, HIV
96  2018 Implications of New Cholesterol Treatment Guidelines on Statin Utilization, Intensity, and Costs in Active Duty Service Members. ---
97  2018 Intra-aortic balloon pump: current evidence & future perspectives. IABP
98  2018 Machine Learning Outperforms ACC / AHA CVD Risk Calculator in MESA. CVD, ML, SVM s
99  2018 Novel method versus the Friedewald method for estimating low-density lipoprotein cholesterol in determination of the eligibility for statin treatment for primary prevention in the United States. ASCVD, CI, LDL-C
100  2018 Optimisation of lipids for prevention of cardiovascular disease in a primary care. ASCVD